Sign In
News Digest /
Ticker: REGN
Ticker: REGN
07:00am, Friday, Aug 01, 2025
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) recently reported its financial performance for the second quarter of 2025. Here's a concise overview of the highlights from their income statement along with pertinent company insights:
Positive Aspects:
Revenues: Total revenues increased to $3,675...
09:10am, Friday, May 30, 2025
UiPath shares surged 12% after a strong Q1 report, boosting revenue guidance. Ulta Beauty rose 9% with improved forecasts, while American Eagle dipped 7% on losses. Gap fell 13% after flat sales projections. Zscaler gained 6% on exceeding estimates. Traders should stay alert.
08:30am, Friday, May 30, 2025
Shares of Regeneron Pharmaceuticals (NASDAQ: REGN) plummeted nearly 9% in pre-market trading after mixed results from its COPD treatment trial, itepekimab. Analysts express concerns about its market viability against Dupixent, raising uncertainties for investors.
07:00am, Tuesday, Apr 29, 2025
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) recently reported its Q1 2025 financial results, presenting a mixed bag of outcomes from its income statement and ongoing operations.
Key Highlights:
Total Revenues: $3.03 billion, down from $3.15 billion in Q1 2024.
Net Income: $808.7 million, up f...